Amanote Research

Amanote Research

    RegisterSign In

Harnessing the Immune System to Fight Cancer With Toll-Like Receptor and RIG-I-like Receptor Agonists

Pharmacological Research - United States
doi 10.1016/j.phrs.2019.03.001
Full Text
Open PDF
Abstract

Available in full text

Categories
Pharmacology
Date

April 1, 2020

Authors
Carole BourquinAurélien PommierChristian Hotz
Publisher

Elsevier BV


Related search

Toll-Like Receptor System and Endometriosis

Journal of Obstetrics and Gynaecology Research
MedicineGynecologyObstetrics
2013English

Targeting Cellular and Tissue HIV Reservoirs With Toll-Like Receptor Agonists

Frontiers in Immunology
AllergyImmunology
2019English

Activation of RIG-I-like Receptor Signal Transduction

Critical Reviews in Biochemistry and Molecular Biology
BiochemistryMolecular Biology
2011English

Toll-Like Receptor-4 Modulation for Cancer Immunotherapy

Frontiers in Immunology
AllergyImmunology
2014English

Rb/E2f1 Regulates the Innate Immune Receptor Toll-Like Receptor 3 in Epithelial Cells

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2012English

Toll-Like Receptor 2 (TLR2)

Science-Business eXchange
2009English

Association Between Toll-Like Receptor 4 (Thr399Ile and Asp299Gly), Toll-Like Receptor 2 196-174 Deletion Polymorphisms With Cryptosporidiosis

Journal of Biosciences and Medicines
2016English

Toll Like Receptor-9 Mediated Invasion in Breast Cancer

2012English

Toll Like Receptor-9 Mediated Invasion in Breast Cancer

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy